Walleye Capital’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
126,259
+71,677
| +131% | +$583K | ﹤0.01% | 823 |
|
|
2025
Q1 | $428K | Buy |
+54,582
| New | +$428K | ﹤0.01% | 1134 |
|
|
2024
Q4 | – | Sell |
-238,544
| Closed | -$3.65M | – | 2548 |
|
|
2024
Q3 | $3.65M | Buy |
+238,544
| New | +$3.65M | 0.01% | 531 |
|
|
2024
Q2 | – | Sell |
-17,691
| Closed | -$334K | – | 2907 |
|
|
2024
Q1 | $334K | Sell |
17,691
-326,127
| -95% | -$6.16M | ﹤0.01% | 1587 |
|
|
2023
Q4 | $6.57M | Buy |
343,818
+174,024
| +102% | +$3.32M | 0.01% | 285 |
|
|
2023
Q3 | $3.05M | Buy |
169,794
+7,328
| +5% | +$132K | 0.01% | 517 |
|
|
2023
Q2 | $3.3M | Sell |
162,466
-253,221
| -61% | -$5.14M | 0.01% | 385 |
|
|
2023
Q1 | $7.58M | Buy |
+415,687
| New | +$7.58M | 0.11% | 192 |
|
|
2021
Q3 | – | Sell |
-86,438
| Closed | -$2.37K | – | 1747 |
|
|
2021
Q2 | $2.37K | Buy |
+86,438
| New | +$2.37K | 0.08% | 198 |
|
|
2020
Q4 | – | Sell |
-10,253
| Closed | -$176K | – | 1073 |
|
|
2020
Q3 | $176K | Buy |
+10,253
| New | +$176K | 0.02% | 627 |
|